301 related articles for article (PubMed ID: 28166834)
1. Downregulation of miR-130b~301b cluster is mediated by aberrant promoter methylation and impairs cellular senescence in prostate cancer.
Ramalho-Carvalho J; Graça I; Gomez A; Oliveira J; Henrique R; Esteller M; Jerónimo C
J Hematol Oncol; 2017 Feb; 10(1):43. PubMed ID: 28166834
[TBL] [Abstract][Full Text] [Related]
2. An integrated view of the role of miR-130b/301b miRNA cluster in prostate cancer.
Fort RS; Mathó C; Oliveira-Rizzo C; Garat B; Sotelo-Silveira JR; Duhagon MA
Exp Hematol Oncol; 2018; 7():10. PubMed ID: 29744254
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-27a-5p regulation by promoter methylation and MYC signaling in prostate carcinogenesis.
Barros-Silva D; Costa-Pinheiro P; Duarte H; Sousa EJ; Evangelista AF; Graça I; Carneiro I; Martins AT; Oliveira J; Carvalho AL; Marques MM; Henrique R; Jerónimo C
Cell Death Dis; 2018 Feb; 9(2):167. PubMed ID: 29415999
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia induced microRNA-301b-3p overexpression promotes proliferation, migration and invasion of prostate cancer cells by targeting LRP1B.
Zheng H; Bai L
Exp Mol Pathol; 2019 Dec; 111():104301. PubMed ID: 31442444
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia-Responsive Mir-301a and Mir-301b Promote Radioresistance of Prostate Cancer Cells via Downregulating NDRG2.
Wang W; Liu M; Guan Y; Wu Q
Med Sci Monit; 2016 Jun; 22():2126-32. PubMed ID: 27327120
[TBL] [Abstract][Full Text] [Related]
6. MiR-130b suppresses prostate cancer metastasis through down-regulation of MMP2.
Chen Q; Zhao X; Zhang H; Yuan H; Zhu M; Sun Q; Lai X; Wang Y; Huang J; Yan J; Yu J
Mol Carcinog; 2015 Nov; 54(11):1292-300. PubMed ID: 25154741
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor (TGF) β1 acted through miR-130b to increase integrin α5 to promote migration of colorectal cancer cells.
Yi R; Li Y; Wang F; Gu J; Isaji T; Li J; Qi R; Zhu X; Zhao Y
Tumour Biol; 2016 Aug; 37(8):10763-73. PubMed ID: 26873488
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic disruption of miR-130a promotes prostate cancer by targeting SEC23B and DEPDC1.
Ramalho-Carvalho J; Martins JB; Cekaite L; Sveen A; Torres-Ferreira J; Graça I; Costa-Pinheiro P; Eilertsen IA; Antunes L; Oliveira J; Lothe RA; Henrique R; Jerónimo C
Cancer Lett; 2017 Jan; 385():150-159. PubMed ID: 27984115
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic silencing of miR-130b in ovarian cancer promotes the development of multidrug resistance by targeting colony-stimulating factor 1.
Yang C; Cai J; Wang Q; Tang H; Cao J; Wu L; Wang Z
Gynecol Oncol; 2012 Feb; 124(2):325-34. PubMed ID: 22005523
[TBL] [Abstract][Full Text] [Related]
10. miR-130b-3p/301b-3p negatively regulated Rb1cc1 expression on myogenic differentiation of chicken primary myoblasts.
Xue J; Xue J; Zhang J; Li D; Jiang L
Biotechnol Lett; 2017 Nov; 39(11):1611-1619. PubMed ID: 28721582
[TBL] [Abstract][Full Text] [Related]
11. Deregulated microRNAs in triple-negative breast cancer revealed by deep sequencing.
Chang YY; Kuo WH; Hung JH; Lee CY; Lee YH; Chang YC; Lin WC; Shen CY; Huang CS; Hsieh FJ; Lai LC; Tsai MH; Chang KJ; Chuang EY
Mol Cancer; 2015 Feb; 14():36. PubMed ID: 25888956
[TBL] [Abstract][Full Text] [Related]
12. Microrna-217 modulates human skin fibroblast senescence by directly targeting DNA methyltransferase 1.
Wang B; Du R; Xiao X; Deng ZL; Jian D; Xie HF; Li J
Oncotarget; 2017 May; 8(20):33475-33486. PubMed ID: 28380423
[TBL] [Abstract][Full Text] [Related]
13. Methylation-associated miR-193b silencing activates master drivers of aggressive prostate cancer.
Mazzu YZ; Yoshikawa Y; Nandakumar S; Chakraborty G; Armenia J; Jehane LE; Lee GM; Kantoff PW
Mol Oncol; 2019 Sep; 13(9):1944-1958. PubMed ID: 31225930
[TBL] [Abstract][Full Text] [Related]
14. Hypermethylation of the GABRE~miR-452~miR-224 promoter in prostate cancer predicts biochemical recurrence after radical prostatectomy.
Kristensen H; Haldrup C; Strand S; Mundbjerg K; Mortensen MM; Thorsen K; Ostenfeld MS; Wild PJ; Arsov C; Goering W; Visakorpi T; Egevad L; Lindberg J; Grönberg H; Høyer S; Borre M; Ørntoft TF; Sørensen KD
Clin Cancer Res; 2014 Apr; 20(8):2169-81. PubMed ID: 24737792
[TBL] [Abstract][Full Text] [Related]
15. Frequent 14-3-3 sigma promoter methylation in benign and malignant prostate lesions.
Henrique R; Jerónimo C; Hoque MO; Carvalho AL; Oliveira J; Teixeira MR; Lopes C; Sidransky D
DNA Cell Biol; 2005 Apr; 24(4):264-9. PubMed ID: 15812243
[TBL] [Abstract][Full Text] [Related]
16. miR-34c is downregulated in prostate cancer and exerts tumor suppressive functions.
Hagman Z; Larne O; Edsjö A; Bjartell A; Ehrnström RA; Ulmert D; Lilja H; Ceder Y
Int J Cancer; 2010 Dec; 127(12):2768-76. PubMed ID: 21351256
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic-induced repression of microRNA-205 is associated with MED1 activation and a poorer prognosis in localized prostate cancer.
Hulf T; Sibbritt T; Wiklund ED; Patterson K; Song JZ; Stirzaker C; Qu W; Nair S; Horvath LG; Armstrong NJ; Kench JG; Sutherland RL; Clark SJ
Oncogene; 2013 Jun; 32(23):2891-9. PubMed ID: 22869146
[TBL] [Abstract][Full Text] [Related]
18. A multiplatform approach identifies miR-152-3p as a common epigenetically regulated onco-suppressor in prostate cancer targeting
Ramalho-Carvalho J; Gonçalves CS; Graça I; Bidarra D; Pereira-Silva E; Salta S; Godinho MI; Gomez A; Esteller M; Costa BM; Henrique R; Jerónimo C
Clin Epigenetics; 2018; 10():40. PubMed ID: 29599847
[TBL] [Abstract][Full Text] [Related]
19. LncRNA BRCAT54 is downregulated and inhibits cancer cell proliferation by downregulating miR-130b-3p through methylation in prostate cancer.
Liang H; Lu Y; Huang X; Ye T
J Biochem Mol Toxicol; 2024 Jan; 38(1):e23552. PubMed ID: 37888834
[TBL] [Abstract][Full Text] [Related]
20. MiR-193b promoter methylation accurately detects prostate cancer in urine sediments and miR-34b/c or miR-129-2 promoter methylation define subsets of clinically aggressive tumors.
Torres-Ferreira J; Ramalho-Carvalho J; Gomez A; Menezes FD; Freitas R; Oliveira J; Antunes L; Bento MJ; Esteller M; Henrique R; Jerónimo C
Mol Cancer; 2017 Jan; 16(1):26. PubMed ID: 28143614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
